These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 33557250)
1. TREM2 Mediates Microglial Anti-Inflammatory Activations in Alzheimer's Disease: Lessons Learned from Transcriptomics. Xue F; Du H Cells; 2021 Feb; 10(2):. PubMed ID: 33557250 [TBL] [Abstract][Full Text] [Related]
2. TREM2 signalling as a multifaceted player in brain homoeostasis and a potential target for Alzheimer's disease treatment. Ayyubova G Eur J Neurosci; 2023 Feb; 57(4):718-733. PubMed ID: 36637116 [TBL] [Abstract][Full Text] [Related]
3. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease. Zhou Y; Song WM; Andhey PS; Swain A; Levy T; Miller KR; Poliani PL; Cominelli M; Grover S; Gilfillan S; Cella M; Ulland TK; Zaitsev K; Miyashita A; Ikeuchi T; Sainouchi M; Kakita A; Bennett DA; Schneider JA; Nichols MR; Beausoleil SA; Ulrich JD; Holtzman DM; Artyomov MN; Colonna M Nat Med; 2020 Jan; 26(1):131-142. PubMed ID: 31932797 [TBL] [Abstract][Full Text] [Related]
4. Microglial TREM2 at the Intersection of Brain Aging and Alzheimer's Disease. Qu W; Li L Neuroscientist; 2023 Jun; 29(3):302-316. PubMed ID: 34470515 [TBL] [Abstract][Full Text] [Related]
5. The Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) as Expression of the Relationship between Microglia and Alzheimer's Disease: A Novel Marker for a Promising Pathway to Explore. Gussago C; Casati M; Ferri E; Arosio B J Frailty Aging; 2019; 8(2):54-56. PubMed ID: 30997915 [TBL] [Abstract][Full Text] [Related]
6. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation. Zheng H; Liu CC; Atagi Y; Chen XF; Jia L; Yang L; He W; Zhang X; Kang SS; Rosenberry TL; Fryer JD; Zhang YW; Xu H; Bu G Neurobiol Aging; 2016 Jun; 42():132-41. PubMed ID: 27143430 [TBL] [Abstract][Full Text] [Related]
7. TREM2, microglia, and Alzheimer's disease. Qin Q; Teng Z; Liu C; Li Q; Yin Y; Tang Y Mech Ageing Dev; 2021 Apr; 195():111438. PubMed ID: 33516818 [TBL] [Abstract][Full Text] [Related]
8. Alzheimer's Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia. Reich M; Paris I; Ebeling M; Dahm N; Schweitzer C; Reinhardt D; Schmucki R; Prasad M; Köchl F; Leist M; Cowley SA; Zhang JD; Patsch C; Gutbier S; Britschgi M Front Immunol; 2020; 11():617860. PubMed ID: 33613545 [TBL] [Abstract][Full Text] [Related]
9. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice. Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771 [TBL] [Abstract][Full Text] [Related]
10. Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer's disease. Toomey CE; Heywood W; Benson BC; Packham G; Mills K; Lashley T Brain Pathol; 2020 Jul; 30(4):794-810. PubMed ID: 32267026 [TBL] [Abstract][Full Text] [Related]
11. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway. Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724 [TBL] [Abstract][Full Text] [Related]
12. TREM2 and the Progression of Alzheimer's Disease. Gao L; Jiang T; Yao X; Yu L; Yang X; Li Y Curr Neurovasc Res; 2017; 14(2):177-183. PubMed ID: 28393702 [TBL] [Abstract][Full Text] [Related]
13. The role of TREM2 in Alzheimer's disease; evidence from transgenic mouse models. Karanfilian L; Tosto MG; Malki K Neurobiol Aging; 2020 Feb; 86():39-53. PubMed ID: 31727362 [TBL] [Abstract][Full Text] [Related]
14. A cell therapy approach to restore microglial Trem2 function in a mouse model of Alzheimer's disease. Yoo Y; Neumayer G; Shibuya Y; Mader MM; Wernig M Cell Stem Cell; 2023 Aug; 30(8):1043-1053.e6. PubMed ID: 37541210 [TBL] [Abstract][Full Text] [Related]
15. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease. Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease. Jiang T; Tan L; Zhu XC; Zhang QQ; Cao L; Tan MS; Gu LZ; Wang HF; Ding ZZ; Zhang YD; Yu JT Neuropsychopharmacology; 2014 Dec; 39(13):2949-62. PubMed ID: 25047746 [TBL] [Abstract][Full Text] [Related]
17. Long-term running exercise improves cognitive function and promotes microglial glucose metabolism and morphological plasticity in the hippocampus of APP/PS1 mice. Zhang SS; Zhu L; Peng Y; Zhang L; Chao FL; Jiang L; Xiao Q; Liang X; Tang J; Yang H; He Q; Guo YJ; Zhou CN; Tang Y J Neuroinflammation; 2022 Feb; 19(1):34. PubMed ID: 35123512 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of TREM2/DAP12 complex affecting β-amyloid plaque deposition in Alzheimer's disease modeled mice through mediating inflammatory response. Cui X; Qiao J; Liu S; Wu M; Gu W Brain Res Bull; 2021 Jan; 166():21-28. PubMed ID: 33053435 [TBL] [Abstract][Full Text] [Related]
19. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice. Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699 [TBL] [Abstract][Full Text] [Related]
20. TREM2 ectodomain and its soluble form in Alzheimer's disease. Yang J; Fu Z; Zhang X; Xiong M; Meng L; Zhang Z J Neuroinflammation; 2020 Jul; 17(1):204. PubMed ID: 32635934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]